Adherence with postdischarge venous thromboembolism chemoprophylaxis recommendations after colorectal cancer surgery among elderly medicare beneficiaries

Annals of Surgery

Volumn 260, Issue 1, 2014, Pages 103-108

  Merkow, Ryan P ^a,b   Bilimoria, Karl Y ^a   Sohn, Min Woong ^a,c   Oh, Elissa H ^a   Sellers, Morgan M ^a   Paruch, Jennifer L ^a,b   Chung, Jeanette W ^a   Bentrem, David J ^a,d  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c HINES VA HOSPITAL   (United States)

^d JESSE BROWN VA MEDICAL CENTER   (United States)

Author keywords

cancer; colorectal; prophylaxis; surgery; venous thromboembolism

Indexed keywords

ANTICOAGULANT AGENT; LOW MOLECULAR WEIGHT HEPARIN;

AGED; CHEMOPROPHYLAXIS; COLORECTAL CANCER; CONFERENCE PAPER; EDUCATIONAL STATUS; ELIXHAUSER COMORBIDITY INDEX; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICARE; PATIENT COMPLIANCE; PRIORITY JOURNAL; RECTUM CANCER; RECTUM RESECTION; VENOUS THROMBOEMBOLISM;

AGED; AGED, 80 AND OVER; CHEMOPREVENTION; COLORECTAL NEOPLASMS; COLORECTAL SURGERY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MEDICARE; PATIENT COMPLIANCE; PATIENT DISCHARGE; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; UNITED STATES; VENOUS THROMBOEMBOLISM;

EID: 84902272601     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0000000000000296     Document Type: Conference Paper

References (28)

1. Elting LS, Escalante CP, Cooksley C, et al. Outcomes and cost of deep venous thrombosis among patients with cancer. Arch Intern Med. 2004;164:1653-1661.
2. Kakkar AK, Haas S,Wolf H, et al. Evaluation of perioperative fatal pulmonary embolism and death in cancer surgical patients: the MC-4 cancer substudy. Thromb Haemost. 2005;94:867-871.
3. Agnelli G, Bolis G, Capussotti L, et al. A clinical outcome-based prospective study on venous thromboembolism after cancer surgery: the@RISTOS project. Ann Surg. 2006;243:89-95.
4. Merkow RP, Bilimoria KY, McCarter MD, et al. Post-discharge venous thromboembolism after cancer surgery: extending the case for extended prophylaxis. Ann Surg. 2011;254:131-137.
5. Bergqvist D, Agnelli G, Cohen AT, et al. Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer. N Engl J Med. 2002;346:975-980.
6. Rasmussen MS, Jorgensen LN, Wille-Jorgensen P. Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery. Cochrane Database Syst Rev. 2009;1:CD004318.
7. Rasmussen MS, Jorgensen LN, Wille-Jorgensen P, et al. Prolonged prophylaxis with dalteparin to prevent late thromboembolic complications in patients undergoing major abdominal surgery: a multicenter randomized open-label study. J Thromb Haemost. 2006;4:2384-2390.
8. Kakkar VV, Balibrea JL, Martinez-Gonzalez J, et al. Extended prophylaxis with bemiparin for the prevention of venous thromboembolism after abdominal or pelvic surgery for cancer: the CANBESURE randomized study. J Thromb Haemost. 2010;8:1223-1229.
9. Lyman GH, Khorana AA, Falanga A, et al. American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer. J Clin Oncol. 2007;25:5490-5505.
10. NCCN Clinical Practice Guidelines in Oncology. Venous Thromboembolic Disease, Version 1. 2013. http://www.nccn.org. Accessed February 15, 2013.
11. Gould MK, Garcia DA, Wren SM, et al. Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(suppl 2):e227S-e277S.
12. Department of Health and Human Services. The International Classification of Diseases. 9th revised. Clinical modification: ICD-9 CM. Washington, DC: Government Printing Office; 1998.
13. Elixhauser A, Steiner C, Harris DR, et al. Comorbidity measures for use with administrative data. Med Care. 1998;36:8-27.
14. Williams RL. A note on robust variance estimation for cluster-correlated data. Biometrics. 2000;56:645-646.
15. Quality Net. Surgical Care Improvement Project (SCIP) Project Information. http://www.qualitynet.org. Accessed June 30, 2010.
16. National Quality Forum. http://www.qualityforum.org. Accessed January 30, 2012.
17. The Office of the Federal Register. Centers for Medicare and Medicaid Services Fiscal Year 2013 Inpatient Prospective Payment System Proposed Rule. https://www.federalregister.gov/articles/2013/08/19/2013-18956/medicareprogram- hospital-inpatient-prospective-payment-systems-for-acute-carehospitals- and-the. Accessed April 30, 2012.
18. Hammond J, Kozma C, Hart JC, et al. Rates of venous thromboembolism among patients with major surgery for cancer. Ann Surg Oncol. 2011;18:3240-3247.
19. White RH, Zhou H, Romano PS. Incidence of symptomatic venous thromboembolism after different elective or urgent surgical procedures. Thromb Haemost. 2003;90:446-455.
20. Bottaro FJ, Elizondo MC, Doti C, et al. Efficacy of extended thromboprophylaxis in major abdominal surgery: what does the evidence show? A meta-analysis. Thromb Haemost. 2008;99:1104-1111.
21. Amin AN, Lin J, Ryan A. Need to improve thromboprophylaxis across the continuum of care for surgical patients. Adv Ther. 2010;27: 81-93.
22. Colwell CW, Jr, Pulido P, Hardwick ME, et al. Patient compliance with outpatient prophylaxis: an observational study. Orthopedics. 2005;28: 143-147.
23. Bergqvist D, Arcelus JI, Felicissimo P, et al. Post-discharge compliance to venous thromboembolism prophylaxis in high-risk orthopaedic surgery: results from the ETHOS registry. Thromb Haemost. 2012;107: 280-287.
24. Rasmussen MS, Jorgensen LN, Wille-Jorgensen P. Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery. Cochrane Database Syst Rev. 2009;1:CD004318.
25. MerkowRP,Hall BL, CohenME, et al.Validity and feasibility of theAmerican College of Surgeons Colectomy Composite Outcome Quality Measure. Ann Surg. 2013;257:483-489.
26. RahmeE,DasguptaK,BurmanM, et al. Postdischarge thromboprophylaxis and mortality risk after hip-or knee-replacement surgery. CMAJ. 2008;178:1545-1554.
27. Cain K, Schmeler KM, Langley G, et al. Patient cost associated with filling a prescription for extended-duration venous thromboembolism (VTE) prophylaxis following surgery for gynecologic cancer. Gynecol Oncol. 2012;127: 18-21.
28. WattsAC,Howie CR, Simpson AH. Assessment of a self-administration protocol for extended subcutaneous thromboprophylaxis in lower limb arthroplasty. J Bone Joint Surg. 2006;88:107-110.